Overall median survival was higher in participants taking quizartinib, according to results from QuANTUM-First trial.
Melek Hursid, PharmD, MBA
Advertisement
Articles by Melek Hursid, PharmD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
How mRNA and Protein-Based COVID-19 Vaccines Work
4
Ixekizumab, Tirzepatide Maintains Efficacy in Psoriatic Disease
5